nprnews_____ = ||| lubuntu at wor2|||New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||Cambridge, Mass.-based Moderna, Inc. is reporting preliminary data suggesting its COVID-19 vaccine is safe and appears to be triggering an immune response in test subjects.


New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial

A view of Moderna headquarters in Cambridge, Mass., earlier this month. Moderna is touting preliminary data from a limited coronavirus vaccine trial.

Maddie Meyer/Getty Images


hide caption

toggle caption

Maddie Meyer/Getty Images


Coronavirus Live Updates


New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial



Cambridge, Mass.-based Moderna, Inc. is reporting preliminary data suggesting its COVID-19 vaccine is safe and appears to be triggering an immune response in test subjects.


Loading…

FN: [[IN THE CLEAR]] Barr does not expect criminal investigation of Obama or Biden as result of Durham probe ((lubuntu at wor2))

=”https://www.foxnews.com/politics/barr-durham-probe“>Barr does not expect criminal investigation of Obama or Biden as result of Durham probe

FN: [[USAMA’S SOLDIER]] FBI cracks Pensacola Navy shooter's iPhone after Apple refuses to help, finds Al Qaeda contacts ((lubuntu at wor2))

=”https://www.foxnews.com/us/nas-pensacola-shooting-update“>FBI cracks Pensacola Navy shooter’s iPhone after Apple refuses to help, finds Al Qaeda contacts

AN: Abbott Labs pushes back on criticism that company’s rapid COVID-19 testing is highly inaccurate ((americasnewsroom__)) ((lubuntu at wor2))

John Hackett, vice president of applied research and technology at Abbott Labs, stands behind the tests on ‘America’s Newsroom.’

Design a site like this with WordPress.com
Get started